UNSPSC 51384518: Tiaprofenic acid

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H12O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1LS1T6R34C, chemically known as 2-thiopheneacetic acid, 5-benzoyl-alpha-methyl- but generally known as tiaprofenic acid, which bears US NIH Compound Identifier 5468. European Medicines Agency schedules Tiaprofenic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11011MIG. The term TIAPROFENIC ACID is an International Non-Proprietary Name.

UNSPSC 51384518 Tiaprofenic acid, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The three recent opportunities tagged to this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—none of which concern tiaprofenic acid, a nonsteroidal anti-inflammatory drug. The mismatch suggests either tagging inconsistency in the source data or that this code does not represent active purchasing categories in current state and local procurement.

The recent opportunities do reveal broader pharmaceutical procurement patterns across state and local government. Seminole County, Florida is procuring naloxone and drug deactivation systems through competitive bidding (IFB60459723LAS, response deadline July 26, 2023), with quarterly deliveries required and FEMA funding involvement. The Texas Health and Human Services Commission issued a Request for Information in April 2026 to explore direct-to-manufacturer prescription fulfillment models. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, with awards effective July 1, 2026, requiring vendors to work through three authorized wholesalers and maintain pricing compliance across multiple formats. Geographic activity spans Florida, Texas, and the MMCAP multistate consortium (including Oregon and other participating jurisdictions), with issuers ranging from county health departments to state HHS commissions and cooperative purchasing organizations. No current opportunities directly involving tiaprofenic acid are evident in the source material.